The journal "Immunopharmacology and Immunotoxicology" focuses on preclinical and clinical drug discovery and development related to the immune system. Research topics include the immunomodulatory effects of various compounds (including small molecules and biologics) on immune-active cells and immune responses, as well as the immunotoxicity of exogenous substances and drugs. The journal is particularly interested in studies that describe the mechanisms of specific compounds (rather than extracts) and prioritizes preclinical and clinical research on immunotherapy for diseases such as chronic inflammation, allergies, autoimmune disorders, and cancer. Topics of special interest include the effects of small molecules, vaccines and biologics targeting central immune pathways, and cell-based therapies, including dendritic cell therapy, T cell adoptive transfer, and stem cell therapy. Publications pointing to potential new drug targets within the immune system or novel techniques for immunopharmacological drug development are also welcomed. The journal covers areas such as infection, allergy, inflammation, tumor immunology, degenerative diseases, immunodeficiency, neurology, and atherosclerosis. "Immunopharmacology and Immunotoxicology" accepts original manuscripts, brief communications, reviews, mini-reviews, clinical trials, and clinical case reports, provided that the reported results are based on original, clinical, or unpublished basic research in any language (excluding abstracts related to papers presented at scientific meetings and symposia).